N
NEO icon

Nuveen’s NeoGenomics NEO Stock Holding History

Nuveen’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.11M Sell
419,450
-4,143
-1% -$43.6K ﹤0.01% 2092
2025
Q4 		$4.98M Sell
423,593
-285,578
-40% -$3.08M ﹤0.01% 1907
2025
Q3 		$5.47M Buy
709,171
+284,088
+67% +$1.99M ﹤0.01% 1868
2025
Q2 		$3.11M Buy
425,083
+79,393
+23% +$641K ﹤0.01% 2105
2025
Q1 		$3.28M Buy
345,690
+23
+0% +$287 ﹤0.01% 2130
2024
Q4 		$5.7M Sell
345,667
-98,179
-22% -$1.52M ﹤0.01% 1922
2024
Q3 		$6.55M Buy
443,846
+1,096
+0.2% +$17.1K ﹤0.01% 1860
2024
Q2 		$6.14M Sell
442,750
-177,521
-29% -$2.52M ﹤0.01% 1843
2024
Q1 		$9.75M Sell
620,271
-127,382
-17% -$1.97M ﹤0.01% 1601
2023
Q4 		$12.1M Sell
747,653
-59,095
-7% -$967K ﹤0.01% 1470
2023
Q3 		$9.92M Sell
806,748
-587
-0.1% -$8.73K ﹤0.01% 1491
2023
Q2 		$13M Buy
807,335
+48,670
+6% +$802K ﹤0.01% 1346
2023
Q1 		$13.2M Sell
758,665
-149,521
-16% -$2.13M ﹤0.01% 1303
2022
Q4 		$8.39M Buy
908,186
+342,326
+60% +$3.19M ﹤0.01% 1609
2022
Q3 		$4.87M Sell
565,860
-482,110
-46% -$4.79M ﹤0.01% 1919
2022
Q2 		$8.54M Buy
1,047,970
+379,580
+57% +$3.62M ﹤0.01% 1618
2022
Q1 		$11.5M Sell
668,390
-21,177
-3% -$446K ﹤0.01% 1554
2021
Q4 		$23.5M Sell
689,567
-59,934
-8% -$2.35M 0.01% 1119
2021
Q3 		$36.2M Sell
749,501
-142,178
-16% -$6.58M 0.01% 867
2021
Q2 		$40.3M Buy
891,679
+8,027
+0.9% +$356K 0.01% 871
2021
Q1 		$42.6M Buy
883,652
+104,285
+13% +$5.43M 0.01% 808
2020
Q4 		$42M Buy
779,367
+74,693
+11% +$3.38M 0.01% 792
2020
Q3 		$26M Buy
704,674
+40,493
+6% +$1.51M 0.01% 912
2020
Q2 		$20.6M Sell
664,181
-503,256
-43% -$13.9M 0.01% 1030
2020
Q1 		$32.2M Buy
1,167,437
+77,113
+7% +$2.31M 0.02% 651
2019
Q4 		$31.9M Sell
1,090,324
-47,437
-4% -$1.13M 0.01% 912
2019
Q3 		$21.8M Buy
1,137,761
+227,756
+25% +$5.34M 0.01% 1077
2019
Q2 		$20M Buy
+910,005
New +$20M 0.01% 1153

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nuveen's NEO Position: Q1 2026 in Review

Nuveen reduced its NeoGenomics (NEO) stake by 0.98% in Q1 2026, selling an estimated $43.6K and leaving 419,450 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2092.

Nuveen first reported a position in NEO in Q2 2019 and has held it in 28 quarters since. The position peaked at $42.6M in Q1 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Nuveen held 419,450 shares of NeoGenomics worth $3.11M as of Q1 2026.
  • Nuveen sold 4,143 NeoGenomics shares in Q1 2026, an estimated $43.6K.
  • NeoGenomics made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2092 holding.
  • Nuveen first reported a position in NeoGenomics in Q2 2019 and has held it in 28 quarters since.
  • Nuveen's NeoGenomics position peaked at $42.6M in Q1 2021.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.